Ha habido 50 transacciones internas recientes registradas para Monopar Therapeutics Inc. (MNPR), incluyendo 23 compras y 23 ventas. El total de compras internas fue valorado en $10.38M y el total de ventas internas en $36.81M.
Internos destacados con actividad reciente incluyen Robinson Chandler, Cittadine Andrew, Rodriguez Susan. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — MNPR
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-31 |
Robinson Chandler |
Chief Executive Officer |
Retención Fiscal de RSU |
1,972 |
$54.79 |
$108.05K |
90,478 |
| 2026-03-31 |
Cittadine Andrew |
Chief Operating Officer |
Ejercicio de Opciones (Venta) |
3,514 |
- |
- |
44,753 |
| 2026-03-02 |
Rodriguez Susan |
Officer |
Desconocido |
- |
- |
- |
- |
| 2026-03-02 |
Rodriguez Susan |
Ccso |
Concesión de RSU |
48,728 |
$53.47 |
$2.61M |
48,728 |
| 2026-01-01 |
Rioux Patrice |
Other: Acting Chief Medical Officer |
Concesión de RSU |
2,000 |
$65.30 |
$130.6K |
2,000 |
| 2025-12-31 |
Robinson Chandler |
Chief Executive Officer |
Retención Fiscal de RSU |
2,558 |
$65.30 |
$167.04K |
85,718 |
| 2025-12-31 |
Cittadine Andrew |
Chief Operating Officer |
Ejercicio de Opciones (Venta) |
4,326 |
- |
- |
48,267 |
| 2025-12-26 |
Vu Quan Anh |
Chief Financial Officer |
Compra Informativa |
1,500 |
$69.95 |
$104.93K |
1,500 |
| 2025-12-18 |
Klausner Arthur J |
Director |
Venta Informativa |
461 |
$68.09 |
$31.39K |
8,762 |
| 2025-12-16 |
Klausner Arthur J |
Director |
Otro (Compra) |
7,710 |
- |
- |
13,883 |
| 2025-12-16 |
Hendricks Diane |
10 Percent Owner |
Otro (Venta) |
43,499 |
- |
- |
567,580 |
| 2025-12-02 |
Klausner Arthur J |
Director |
Concesión de RSU |
2,924 |
$75.94 |
$222.05K |
2,924 |
| 2025-12-02 |
Starr Christopher M |
Director |
Concesión de RSU |
2,924 |
$75.94 |
$222.05K |
2,924 |
| 2025-12-02 |
Tsuchimoto Kim R |
Director |
Concesión de RSU |
2,924 |
$75.94 |
$222.05K |
2,924 |
| 2025-12-02 |
Anderson Raymond |
Director |
Concesión de RSU |
2,924 |
$75.94 |
$222.05K |
2,924 |
| 2025-12-02 |
Robinson Chandler |
Chief Executive Officer |
Concesión de RSU |
16,753 |
$75.94 |
$1.27M |
16,753 |
| 2025-12-02 |
Cittadine Andrew |
Chief Operating Officer |
Concesión de RSU |
8,969 |
$75.94 |
$681.11K |
8,969 |
| 2025-12-02 |
Vu Quan Anh |
Chief Financial Officer |
Concesión de RSU |
7,135 |
$75.94 |
$541.83K |
7,135 |
| 2025-12-02 |
Talukdar Lavina |
Director |
Concesión de RSU |
2,924 |
$75.94 |
$222.05K |
2,924 |
| 2025-09-30 |
Robinson Chandler |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
8,726 |
- |
- |
72,599 |
| 2025-09-30 |
Cittadine Andrew |
Chief Operating Officer |
Ejercicio de Opciones (Venta) |
4,327 |
- |
- |
38,674 |
| 2025-09-24 |
Tactic Pharma Llc |
10 Percent Owner |
Venta Informativa |
550,229 |
$63.61 |
$35M |
272,026 |
| 2025-07-14 |
Starr Christopher M |
Director |
Ejercicio de Opciones (ITM) |
16,800 |
$0.01 |
$84.00 |
- |
| 2025-07-14 |
Tsuchimoto Kim R |
Director |
Ejercicio de Opciones (ITM) |
4,704 |
$0.01 |
$23.52 |
- |
| 2025-07-14 |
Robinson Chandler |
Chief Executive Officer |
Ejercicio de Opciones (ITM) |
16,800 |
$0.01 |
$84.00 |
- |
| 2025-06-30 |
Robinson Chandler |
Chief Executive Officer |
Retención Fiscal de RSU |
5,865 |
$35.78 |
$209.85K |
73,472 |
| 2025-06-30 |
Cittadine Andrew |
Chief Operating Officer |
Ejercicio de Opciones (Venta) |
6,863 |
- |
- |
43,001 |
| 2025-04-02 |
Tactic Pharma Llc |
10 Percent Owner |
Venta Informativa |
33,334 |
$35.00 |
$1.17M |
822,255 |
| 2025-03-31 |
Robinson Chandler |
Chief Executive Officer |
Retención Fiscal de RSU |
1,204 |
$36.41 |
$43.84K |
65,993 |
| 2025-03-31 |
Cittadine Andrew |
Chief Operating Officer |
Retención Fiscal de RSU |
744 |
$36.41 |
$27.09K |
41,985 |
| 2025-03-04 |
Klausner Arthur J |
Director |
Concesión de RSU |
11,365 |
$31.70 |
$360.27K |
11,365 |
| 2025-03-04 |
Starr Christopher M |
Director |
Concesión de RSU |
11,365 |
$31.70 |
$360.27K |
11,365 |
| 2025-03-04 |
Tsuchimoto Kim R |
Director |
Concesión de RSU |
11,365 |
$31.70 |
$360.27K |
11,365 |
| 2025-03-04 |
Anderson Raymond |
Director |
Concesión de RSU |
11,365 |
$31.70 |
$360.27K |
11,365 |
| 2025-03-04 |
Robinson Chandler |
Chief Executive Officer |
Retención Fiscal de RSU |
1,759 |
$31.70 |
$55.76K |
63,091 |
| 2025-03-04 |
Cittadine Andrew |
Chief Operating Officer |
Concesión de RSU |
43,445 |
$31.70 |
$1.38M |
43,445 |
| 2025-03-04 |
Talukdar Lavina |
Director |
Concesión de RSU |
5,683 |
$31.70 |
$180.15K |
5,683 |
| 2025-03-03 |
Vu Quan Anh |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-03-03 |
Vu Quan Anh |
Chief Financial Officer |
Concesión de RSU |
25,000 |
$30.93 |
$773.25K |
25,000 |
| 2025-02-21 |
Talukdar Lavina |
Director |
Desconocido |
- |
- |
- |
14,001 |
| 2025-01-28 |
Robinson Chandler |
Chief Executive Officer |
Otro (Compra) |
62,815 |
- |
- |
62,815 |
| 2025-01-01 |
Rioux Patrice |
Other: Acting Chief Medical Officer |
Concesión de RSU |
2,000 |
$22.00 |
$44K |
2,000 |
| 2024-12-31 |
Robinson Chandler |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
4,895 |
- |
- |
24,879 |
| 2024-12-31 |
Cittadine Andrew |
Chief Operating Officer |
Ejercicio de Opciones (Venta) |
1,790 |
- |
- |
11,074 |
| 2024-12-09 |
Tacticgem Llc |
10 Percent Owner |
Otro (Venta) |
1,433,334 |
- |
- |
- |
| 2024-10-28 |
Radhakrishnan Karthik |
Chief Financial Officer |
Compra Informativa |
1,550 |
$16.25 |
$25.19K |
1,550 |
| 2024-09-30 |
Robinson Chandler |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
4,895 |
- |
- |
29,774 |
| 2024-09-30 |
Cittadine Andrew |
Chief Operating Officer |
Ejercicio de Opciones (Venta) |
1,791 |
- |
- |
12,864 |
| 2024-07-01 |
Radhakrishnan Karthik |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-07-01 |
Radhakrishnan Karthik |
Chief Financial Officer |
Concesión de RSU |
125,000 |
$0.74 |
$92.68K |
125,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento